HF3934
PFAS biomonitoring funding provided, and money appropriated.
Legislative Session 94 (2025-2026)
Related bill: SF3884
AI Generated Summary
Purpose
- Provide funding to continue biomonitoring of PFAS (per- and polyfluoroalkyl substances) in eastern metropolitan communities. The money is intended to help measure and track PFAS exposure in people living in that area.
Main Provisions
- An appropriation of money from the Environmental Fund:
- $365,000 for fiscal year 2026.
- $710,000 for fiscal year 2027.
- The funds are designated to be transferred from the Pollution Control Agency to the Commissioner of Health.
- The purpose of the transfer is to support PFAS biomonitoring in eastern metropolitan communities.
- The funds remain available until expended (they do not lapse at a fixed date).
Funding and Administration
- Source of funds: Environmental Fund.
- Agencies involved in the transfer: Pollution Control Agency (receives the funds) and the Commissioner of Health (uses the funds for biomonitoring).
- Scope: Biomonitoring activities specifically targeted to eastern metropolitan communities.
Significance and Impact
- This creates a dedicated funding stream to support ongoing PFAS biomonitoring in a defined region, enabling public health authorities to collect data on PFAS exposure among residents.
- It involves interagency coordination (PCA to Health) to carry out health monitoring activities.
- It does not specify changes to existing laws beyond establishing the funding and transfer arrangement; the primary effect is to provide resources for the biomonitoring program.
Significance to Public Health
- Aims to improve knowledge about PFAS exposure in the East Metro area, which can inform health guidance, risk communication, and potential policy actions based on local data.
Administrative Notes
- Availability “until expended” means the funds must be used until they are fully spent, rather than having a hard end date.
Relevant Terms
PFAS, per- and polyfluoroalkyl substances; biomonitoring; environmental fund; Pollution Control Agency; Commissioner of Health; eastern metropolitan communities; appropriation; fiscal year 2026; fiscal year 2027; transfer; available until expended.
Actions
| Date | Chamber | Where | Type | Name | Committee Name |
|---|---|---|---|---|---|
| March 05, 2026 | House | Action | Introduction and first reading, referred to | Environment and Natural Resources Finance and Policy |
Bill information comes from public records published by the Office of the Revisor of Statutes, the Minnesota House and the Minnesota Senate. AI summaries are written by MinneSlate and are not official. MinneSlate is independent and is not affiliated with the State of Minnesota or the Minnesota Legislature.
Progress through the legislative process
In Committee